Prospects for a dengue vaccine: progress and pitfalls

Area of Science:

• Virology
• Epidemiology
• Immunology

Background:

• Dengue virus is the most prevalent arboviral infection globally.
• Dengue transmission is a growing concern in the continental United States.
• Aedes mosquitoes, the primary vectors for dengue, are found in regions like Missouri.

Purpose of the Study:

• To inform clinicians about the increasing prevalence of dengue in the US.
• To highlight the status of dengue vaccine development.
• To emphasize the importance of understanding protective immunity for future vaccine strategies.

Main Methods:

• Review of current epidemiological data on dengue.
• Overview of ongoing dengue vaccine clinical trials.
• Discussion of immunological research related to dengue.

Main Results:

• Dengue virus has established a presence in the continental United States.
• Five dengue vaccines are currently in human trials.
• Two of these vaccine candidates have been tested at the Saint Louis University Center for Vaccine Development.

Conclusions:

• Clinicians need to be aware of dengue due to its spread and vector prevalence.
• Advancements in understanding dengue immunity enhance the prospects for effective vaccine development.